论文部分内容阅读
泛昔洛韦是一种新型抗水痘－带状疱疹、Ⅰ 型、Ⅱ 型单纯疱疹病毒和 EB病毒的药物。为了研究国产泛昔洛韦片口服治疗免疫正常无并发症的带状疱疹的疗效与安全性，经国家药品监督管理局审定（批准文号： 1998 XL 86号）， 1998年 9～ 12月以卫生部临床药理基地——中国医学科
Famciclovir is a novel anti-varicella-shingles, herpes simplex virus type I, and Epstein-Barr virus. In order to study the efficacy and safety of domestic famciclovir tablets for the oral treatment of herpes zoster without immunocompromising complications, the approval by the State Drug Administration (approval number: 1998 XL 86), 1998 September to December with the Ministry of Health Clinical Pharmacology Base - Chinese Medical Sciences